Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hayat Pharmaceutical Industries CoAMM:HPIC -0.62%48 Operating Margin % is 16.45% as of Jun. 2026, which is 30% below its 10-year median of 23.58. GuruFocus rates AMM:HPIC with a GF Score™ of 48/100. The stock has 8 warning signs investors should review. Among 958 Drug Manufacturers companies, Hayat Pharmaceutical Industries Co ranks better than 67.33% on this metric.
Hayat Pharmaceutical Industries Co operating margin has been in a 5-year decline. The average rate of decline per year is -11.2%.
The historical rank and industry rank for Hayat Pharmaceutical Industries Co's Operating Margin % or its related term are showing as below:
AMM:HPIC'
s Operating Margin % Range Over the Past 10 Years
Min: 13.89 Med: 23.58 Max: 26.09
Current: 13.99
AMM:HPIC's Operating Margin % is ranked better than 67.33% of 958
companies
in the Drug Manufacturers industry
Industry Median: 7.275
vs AMM:HPIC: 13.99
Hayat Pharmaceutical Industries Co (AMM:HPIC) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Hayat Pharmaceutical Industries Co Operating Margin % Related Terms
Hayat Pharmaceutical Industries Co Operating Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hayat Pharmaceutical Industries Co Operating Margin % Chart
AMM:HPIC vs ZTS, UTHR, VTRS: Operating Margin % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Hayat Pharmaceutical Industries Co's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hayat Pharmaceutical Industries Co Operating Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hayat Pharmaceutical Industries Co's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Hayat Pharmaceutical Industries Co's Operating Margin % falls into.
Hayat Pharmaceutical Industries Co Operating Margin % Calculation
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hayat Pharmaceutical Industries Co (AMM:HPIC) has a Operating Margin % of 16.45% as of Jun. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Hayat Pharmaceutical Industries Co and its competitors. This is 30% below median its historical median of 23.58. Over the past decade, Hayat Pharmaceutical Industries Co's Operating Margin % has ranged from 13.89 to 26.09. According to the industry distribution chart, Hayat Pharmaceutical Industries Co ranks #313 out of 958 companies in the Drug Manufacturers industry, placing it in the top 32.7%.
Is Hayat Pharmaceutical Industries Co's Operating Margin % too high?
Hayat Pharmaceutical Industries Co's current Operating Margin % of 16.45% is 30% below median its 10-year median of 23.58. Over the past 10 years, this metric has ranged from a low of 13.89 to a high of 26.09. The Drug Manufacturers industry median Operating Margin % is 7.28. Hayat Pharmaceutical Industries Co's value of 16.45% is 126.1% above this industry median. Based on the distribution chart, Hayat Pharmaceutical Industries Co ranks #313 out of 958 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Hayat Pharmaceutical Industries Co has a GF Score™ of 48/100, reflecting its overall financial health beyond just this single metric.
How does Hayat Pharmaceutical Industries Co's Operating Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Hayat Pharmaceutical Industries Co ranks #313 out of 958 companies for Operating Margin %. This puts Hayat Pharmaceutical Industries Co in the upper half of its industry. The industry median Operating Margin % is 7.28. Hayat Pharmaceutical Industries Co's value of 16.45% is 126.1% above this benchmark. Historically, Hayat Pharmaceutical Industries Co's own Operating Margin % has ranged from 13.89 to 26.09 over the past decade. While the company's 10-year median is 23.58 vs. the industry median of 7.28, Hayat Pharmaceutical Industries Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Drug Manufacturers company?
The median Operating Margin % among Drug Manufacturers companies is 7.28, based on 958 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hayat Pharmaceutical Industries Co's current Operating Margin % of 16.45% is 126.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Hayat Pharmaceutical Industries Co and its competitors. For the Drug Manufacturers industry, the median Operating Margin % is 7.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hayat Pharmaceutical Industries Co's current Operating Margin % is 16.45%, which is 30% below median its own 10-year median of 23.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hayat Pharmaceutical Industries Co stock overvalued right now?
Hayat Pharmaceutical Industries Co (AMM:HPIC) has a current Operating Margin % of 16.45%. The current Operating Margin % is 16.45%, which is 30% below median its 10-year median of 23.58 and 126.1% above the Drug Manufacturers industry median of 7.28. Hayat Pharmaceutical Industries Co's overall GF Score™ is 48/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Hayat Pharmaceutical Industries Co (AMM:HPIC), the current Operating Margin % is 16.45% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Hayat Pharmaceutical Industries Co is a Jordan based pharmaceutical manufacturing company. The princapal activity is producing human and veterinary medicines in all its forms and medical stickers and stockings, in addition to the production of medical supplies, body care lotions, cosmetics, sutures and initiating marketing campgains as well as import and export operations. Its products include Cardiovascular system, Infectious disease, Dermatology, Gastrointestinal system, Inner Ear & Balance, Men's Health, Neurology, Vitamins & Supplements, Women's Health, and Respiratory system. The operations business operating within one geographic sector which is the Hashemite Kingdom of Jordan.
48GF Score
Get the complete analysis for AMM:HPIC
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AMM:HPIC has been successfully added to your 
